DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20203544

Chemosensitizing effect of maitake mushroom extract on carmustine cytotoxicity in human bladder cancer cells

Joel Hillelsohn, Michael Stern, Mina Iskander, Muhammad Choudhury, Sensuke Konno

Abstract


Background: Despite several therapeutic options available for bladder cancer, the outcomes are less satisfactory.  To find a more effective modality, we were interested in the bioactive mushroom extract, PDF, which has been shown to sensitize certain anticancer drugs.  Accordingly, we investigated if cytotoxic effects of several anticancer drugs used on bladder cancer patients could be enhanced with PDF in vitro.

Methods: Human bladder cancer T24 cells were treated with four anticancer drugs, carmustine (BCNU), 5-fluorouracil (5FU), cisplatin (CPL), and doxorubicin (DOX) alone, their combinations, or in combination with PDF, and cell viability was determined.  To explore the anticancer mechanism, the status of glyoxalase I (Gly-I), an enzyme involved in the drug resistance of cancer cells, and oxidative stress that can cause severe cellular injury/damage was also assessed.

Results: BCNU and 5FU alone resulted in a >50% reduction in cell viability but CPL and DOX had no such effects.  Only a combination of BCNU and PDF led to a drastic (~90%) cell viability reduction, accompanied by inactivation of Gly-I and an increase in oxidative stress.  However, any combinations of other drugs and PDF had little effects on cell viability, Gly-I activity, or severity of oxidative stress.

Conclusions: This study shows that anticancer activity of BCNU is significantly potentiated with PDF in T24 cells.  This is rather attributed to inactivated Gly-I and increased oxidative stress.  Therefore, PDF appears to have a chemosensitizing effect capable of enhancing BCNU cytotoxicity, which may offer an alternative, improved therapeutic option for bladder cancer.


Keywords


Bladder cancer cells, Carmustine, Glyoxalase I, Maitake mushroom, Oxidative stress

Full Text:

PDF

References


Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstrom PU, Choi W, et al. Bladder cancer. Lancet. 2016;388:2796-810.

Seigel RL, Miller KD, Jemal A. Cancer statistics 2019. CA Cancer J Clin. 2019;69:7-34.

Shen Z, Shen T, Wientjes MG, O'Donnell MA, Au JL. Intravesical treatments of bladder cancer: review. Pharm Res. 2008;25:1500-10.

Malmstrom PU. Intravesical therapy of superficial bladder cancer. Crit Rev Oncol Hematol. 2003;47:109-26.

Theyer G, Hamilton G. Role of multidrug resistance in tumors of the genitourinary tract. Urology. 1994;44:942-50.

Thornalley PJ. Glutathione-dependent detoxification of α-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors. Chem Biol Interact. 1998;111-112:137-51.

Thornalley PJ. The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem J. 1990;269:1-11.

Vanhoefer U, Yin MB, Harstrick A, Seeber S, Rustum YM. Carbamoylation of glutathione reductase by N,N-bis(2-chloroethyl)-N-nitrosourea associated with inhibition of multidrug resistance protein (MRP) function. Biochem Pharmacol. 1997;53:801-9.

Fullerton SA, Samadi AA, Tortorelis DG, Choudhury MS, Mallouh C, Tazaki H, et al. Induction of apoptosis in human prostatic cancer cells with β-glucan (maitake mushroom polysaccharide). Mol Urol. 2000;4:7-13.

Mizuno T, Zhuang C. Maitake, Grifola frondosa: pharmacological effects. Food Rev Int. 1995;11:135-49.

Adachi K, Nanba H, Kuroda H. Potentiation of host-mediated antitumor activity in mice by β-glucan obtained from Grifola frondosa (maitake). Chem Pharm Bull. 1987;35:262-70.

Nanba H. Antitumor activity of orally administered D-fraction from maitake mushroom (Grifola frondosa). J Naturopath Med. 1993;1:10-15.

Maitake D. fraction obtained IND for clinical study (corporation publication). Paramus, NJ; Maitake Products. Inc; 1998.

Ranganathan S, Tew KD. Analysis of glyoxalase I from normal and tumor tissue from human colon. Biochim Biophys Acta. 1993;1182:311-6.

Dargel R. Lipid peroxidation: a common pathogenetic mechanism? Exp Toxic Pathol. 1992;44:169-81.

Nanba H. Maitake D-fraction: Healing and preventive potential for cancer. J Orthomol Med. 1997;12:43-9.

Venkataraman K, Khurana S, Tai TC. Oxidative stress in aging-matters of the heart and mind. Int J Mol Sci. 2013;14:17897-925.

Navarro-Yepes J, Burns M, Anandhan A, Khalimonchuk O, del Razo LM, Quintanilla-Vega B, et al. Oxidative stress, redox signaling, and autophagy: cell death versus survival. Antioxid Redox Signal. 2014;21:66-85.

Weinstein RS, Kuszak JR, Kluskens LF, Coon JS. P-glycoproteins in pathology: the multidrug resistance gene family in humans. Hum Pathol. 1990;21:34-48.

Tew KD. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 1994;54:4313-20.